• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT281212
Device Problems Human-Device Interface Problem (2949); Insufficient Information (3190)
Patient Problem Rupture (2208)
Event Date 04/24/2018
Event Type  Injury  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.(b)(4).Further information and images were requested.
 
Event Description
On (b)(6) 2018, the patient underwent endovascular procedure using gore® excluder® endoprostheses.It was reported that a gore® excluder® aaa endoprosthesis featuring c3® delivery system (rlt281212/17787609) was advanced and deployed as per gore® excluder® aaa endoprosthesis instructions for use (ifu).Upon ballooning the proximal end, the patients¿ blood pressure dropped due to a rupture in the patient¿s aorta below the left renal artery.Aortic extender components were immediately placed, which did not seal the rupture.The physician gained access from the patients arm to place stents into the renal arteries and sma.The additional pla360400/1551830 device was placed over the renal arteries.A contralateral leg component (plc14100/17218283) was placed to extend ipsilateral side of excluder into right common and plc161200/17674201 was placed to seal in left common.A rlt281212/17590259 was advanced and landed at the celiac artery.A plc16100/17576008 was placed in the ipsilateral side to reinforce and a plc161200/17674205 was placed on the contralateral side.These limbs sealed into the previously placed excluder limbs.Reportedly, the patient continued to have a leak, but was stable and will have another scan.Further information will be provided.It was reported that all devices prepared as per gore® excluder® aaa endoprosthesis instructions for use (ifu).Anatomically, the infrarenal neck was calcified and contained thrombus.Rupture caused by ballooning and vessel integrity.
 
Manufacturer Narrative
Additional information was requested but was not available.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to aneurysm rupture and bleeding.According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), key anatomic elements that may affect successful exclusion of the aneurysm include significant thrombus and / or calcium at the arterial implantation sites, specifically the proximal aortic neck and distal iliac artery interface.Additional considerations for patient selection include but are not limited to patient¿s anatomical suitability for endovascular repair.
 
Event Description
Upon ballooning the proximal end by a reliant balloon (medtronic), the patient's blood pressure dropped due to a rupture in the patient¿s aorta below the left renal artery.Aortic extender components were immediately placed, which did not seal the rupture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
nataliya baramzina
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7515937
MDR Text Key108349694
Report Number3007284313-2018-00156
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/14/2021
Device Catalogue NumberRLT281212
Device Lot Number17787609
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/15/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age81 YR
-
-